Extracellular Matrix Remodeling in Diabetes

Extracellular matrix (ECM) remodeling is a significant aspect of diabetes pathology, impacting tissue structure and function. In diabetes, hyperglycemia induces changes in the composition and organization of the ECM, particularly in tissues such as the kidney, retina, and nerve. Key components of the ECM, including collagen, fibronectin, and glycosaminoglycans, undergo alterations that contribute to fibrosis, inflammation, and impaired tissue repair. This remodeling is driven by various factors, including elevated levels of advanced glycation end products (AGEs) and pro-inflammatory cytokines. Understanding the role of ECM remodeling in diabetes can provide valuable insights into therapeutic strategies aimed at restoring normal tissue architecture and function. Targeting the pathways involved in ECM remodeling may help mitigate the complications associated with diabetes, enhancing patient outcomes and overall health.